Get started
Work

Increased Oral Care Needs and Third Molar Symptoms in Women with Gestational Diabetes Mellitus: A Finnish Gestational Diabetes Case–Control Study

Year: 2022
Type: article
Study design: Observational Study
Abstract: (1) Hyperglycemia and oral pathology accelerate each other in diabetes. We evaluated whether gestational diabetes mellitus (GDM) is associated with self-reported increased oral health care needs and oral symptoms, including third molar symptoms, during pregnancy. (2) Pregnant women with (n = 1030) and without GDM (n = 935) were recruited in this multicenter Finnish Gestational Diabetes study in 2009–2012. Of the women with GDM, 196 (19.0%) receiving pharmacological treatment, 797 (77.0%) receiving diet treatment and 233 (23.0%) with recurrent GDM were analyzed separately. Oral health was assessed using structured questionnaires and analyzed by multivariable logistic regression adjusted for background risk factors. (3) Women with GDM were more likely to report a higher need for oral care than controls (31.1% vs. 24.5%; odds ratio (OR) 1.39; 95% confidence interval (CI) 1.14–1.69), particularly women with recurrent GDM (38.1% vs. 24.5%; OR 1.90; 95% CI 1.40–2.58). Women with pharmacologically treated GDM (46.9%) more often had third molar symptoms than controls (36.1%; OR 1.57; 95% CI 1.15–2.15) than women with diet-treated GDM (38.0%; OR 1.47; 95% CI 1.07–2.02). (4) GDM is associated with perceived oral care needs. Third molar symptoms were associated with pharmacologically treated GDM.
DOI: 10.3390/ijerph191710711
Authors: Jenni Pukkila, Sanna Mustaniemi, Shilpa Lingaiah, Olli-Pekka Lappalainen, Eero Kajantie, Anneli Pouta, Risto Kaaja, Johan G. Eriksson, Hannele Laivuori, Mika Gissler, Marja Vääräsmäki, Elina Keikkala
Institutions: Oulu University Hospital, Finnish Institute for Health and Welfare, University of Oulu, University of Helsinki, Helsinki University Hospital, Norwegian University of Science and Technology, Helsinki Children's Hospital, University of Turku, Turku University Hospital, Agency for Science, Technology and Research, National University of Singapore, Singapore Institute for Clinical Sciences, Folkhälsans Forskningscentrum, Tampere University, Tampere University Hospital, Institute for Molecular Medicine Finland, University of Tampere, HiLIFE – Elämäntieteiden Instituutti, Region Stockholm, Karolinska Institutet
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,618
Funders: Suomen Lääketieteen Säätiö, Yrjö Jahnssonin Säätiö, Medical Research Center Oulu, Fondazione Diabete Ricerca, Academy of Finland, Juho Vainion Säätiö, Novo Nordisk, Signe ja Ane Gyllenbergin Säätiö, Lastentautien Tutkimussäätiö, Sigrid Juséliuksen Säätiö, Novo Nordisk Fonden
OpenAlex ID: W4293537616
FWCI: 0.861
Cites: 28
Cited by: 5
Related to: 10